<jats:sec> OBJECTIVE To determine whether metformin or lifestyle modification can lower rates of all-cause and cause-specific mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. </jats:sec> <jats:sec> RESEARCH DESIGN AND METHODS From 1996 to 1999, 3,234 adults at high risk for type 2 diabetes were randomized to an intensive lifestyle intervention, masked metformin, or placebo. Placebo and lifestyle interventions stopped in 2001, and a modified lifestyle program was offered to everyone, but unmasked study metformin continued in those originally randomized. Causes of deaths through 31 December 2018 were adjudicated by blinded reviews. All-cause and cause-specific mortality hazard ratios (HRs) were estimated from Cox proportional hazards regression models and Fine-Gray models, respectively. </jats:sec> <jats:sec> RESULTS Over a median of 21 years (interquartile range 20–21), 453 participants died. Cancer was the leading cause of death (n = 170), followed by cardiovascular disease (n = 131). Compared with placebo, metformin did not influence mortality from all causes (HR 0.99 [95% CI 0.79, 1.25]), cancer (HR 1.04 [95% CI 0.72, 1.52]), or cardiovascular disease (HR 1.08 [95% CI 0.70, 1.66]). Similarly, lifestyle modification did not impact all-cause (HR 1.02 [95% CI 0.81, 1.28]), cancer (HR 1.07 [95% CI 0.74, 1.55]), or cardiovascular disease (HR 1.18 [95% CI 0.77, 1.81]) mortality. Analyses adjusted for diabetes status and duration, BMI, cumulative glycemic exposure, and cardiovascular risks yielded results similar to those for all-cause mortality. </jats:sec> <jats:sec> CONCLUSIONS Cancer was the leading cause of mortality among adults at high risk for type 2 diabetes. Although metformin and lifestyle modification prevented diabetes, neither strategy reduced all-cause, cancer, or cardiovascular mortality rates. </jats:sec>
Nutritional Aspects to Cardiovascular Diseases and Type 2 Diabetes Mellitus
Hayley E. Billingsley, Emily M. Heiston, Moriah P. Bellissimo, Carl J. Lavie, Salvatore Carbone
https://doi.org/10.1007/s11886-023-02018-x ·
2024, Current Cardiology Reports, №3, с.73-81
Scopus
WoS
Цитувань Crossref:1
Weight Change During the Postintervention Follow-up of Look AHEAD
Rena R. Wing, Rebecca H. Neiberg, Judy L. Bahnson, Jeanne M. Clark, Mark A. Espeland, James O. Hill, Karen C. Johnson, William C. Knowler, KayLoni Olson, Helmut Steinburg, Xavier Pi-Sunyer, Thomas A. Wadden, Holly Wyatt, Jeanne M. Clark, Lee Swartz, Dawn Jiggetts, Jeanne Charleston, Lawrence Cheskin, Nisa M. Maruthur, Scott J. Pilla, Danielle Diggins, Mia Johnson, George A. Bray, Frank L. Greenway, Donna H. Ryan, Catherine Champagne, Valerie Myers, Jeffrey Keller, Tiffany Stewart, Jennifer Arceneaux, Karen Boley, Greta Fry, Lisa Jones, Kim Landry, Melissa Lingle, Marisa Smith, Cora E. Lewis, Sheikilya Thomas, Stephen Glasser, Gareth Dutton, Amy Dobelstein, Sara Hannum, Anne Hubbell, DeLavallade Lee, Phyllis Millhouse, L. Christie Oden, Cathy Roche, Jackie Grant, Janet Turman, David M. Nathan, Valerie Goldman, Linda Delahanty, Mary Larkin, Kristen Dalton, Roshni Singh, Melanie Ruazol, Medha N. Munshi, Sharon D. Jackson, Roeland J.W. Middelbeek, A. Enrique Caballero, Anthony Rodriguez, George Blackburn, Christos Mantzoros, Ann McNamara, Holly Wyatt, James O. Hill, Jeanne Anne Breen, Marsha Miller, Debbie Bochert, Suzette Bossart, Paulette Cohrs, Susan Green, April Hamilton, Eugene Leshchinskiy, Loretta Rome, John P. Foreyt, Molly Gee, Henry Pownall, Ashok Balasubramanyam, Chu-Huang Chen, Peter Jones, Michele Burrington, Allyson Clark Gardner, Sharon Griggs, Michelle Hamilton, Veronica Holley, Sarah Lee, Sarah Lane Liscum, Susan Cantu-Lumbreras, Julieta Palencia, Jennifer Schmidt, Jayne Thomas, Carolyn White, Charlyne Wright, Monica Alvarez, Karen C. Johnson, Beate Griffin, Mace Coday, Donna Valenski, Lisa Jones, Karen Johnson, Karen C. Johnson, Helmut Steinburg, Robert W. Jeffery, Tricia Skarphol, John P. Bantle, J. Bruce Redmon, Kerrin Brelje, Carolyne Campbell, Mary Ann Forseth, Soni Uccellini, Mary Susan Voeller, Blandine Laferrère, Xavier Pi-Sunyer, Jennifer Patricio, Jose Luchsinger, Priya Palta, Sarah Lyon, Kim Kelly, Thomas A. Wadden, Barbara J. Maschak-Carey, Robert I. Berkowitz, Ariana Chao, Renee Davenport, Katherine Gruber, Sharon Leonard, Olivia Walsh, John M. Jakicic, Jacqueline Wesche-Thobaben, Lin Ewing, Andrea Hergenroeder, Mary Korytkowski, Susan Copelli, Rebecca Danchenko, Diane Ives, Juliet Mancino, Lisa Martich, Meghan McGuire, Tracey Y. Murray, Linda Semler, Kathy Williams, Rena R. Wing, Caitlin Egan, Elissa Jelalian, Jeanne McCaffery, Kathryn Demos McDermott, Jessica Unick, Kirsten Annis, Jose DaCruz, Ariana Rafanelli, Helen P. Hazuda, Juan Carlos Isaac, Prepedigna Hernandez, Steven E. Kahn, Edward J. Boyko, Elaine Tsai, Lorena Wright, Karen Atkinson, Ivy Morgan-Taggart, Jolanta Socha, Heidi Urquhart, William C. Knowler, Paula Bolin, Harelda Anderson, Sara Michaels, Ruby Johnson, Patricia Poorthunder, Janelia Smiley, Anne L. Peters, Siran Ghazarian, Elizabeth Beale, Edgar Ramirez, Gabriela Rodriguez, Valerie Ruelas, Sara Serafin-Dokhan, Martha Walker, Marina Perez, Mark A. Espeland, Lynne E. Wagenknecht, Judy L. Bahnson, David Reboussin, Mike E. Miller, Peter Brubaker, Nicholas Pajewski, Michael Bancks, Jingzhong Ding, Gagan Deep, Kathleen Hayden, Stephen R. Rapp, Felicia Simpson, Haiying Chen, Bonnie C. Sachs, Denise Houston, Shyh-Huei Chen, Andrea Anderson, Jerry M. Barnes, Mary Barr, Tara D. Beckner, Delilah R. Cook, Carrie C. Williams, Joni Evans, Katie Garcia, Sarah A. Gaussoin, Carol Kittel, Lea Harvin, Marjorie Howard, James Lovato, Rebecca H. Neiberg, June Pierce, Debbie Steinberg, Christopher Webb, Jennifer Walker, Michael P. Walkup, Carolyn Watkins, Santica M. Marcovina, Jessica Hurting, John J. Albers, Vinod Gaur, Michael Nevitt, Ann Schwartz, John Shepherd, Michaela Rahorst, Lisa Palermo, Susan Ewing, Cynthia Hayashi, Jason Maeda
https://doi.org/10.2337/dc21-1990 ·
2022, Diabetes Care, №6, с.1306-1314
Scopus
WoS
Цитувань Crossref:0
Treatment of type 2 diabetes Therapie des Typ-2-Diabetes
Rüdiger Landgraf, Jens Aberle, Andreas L. Birkenfeld, Baptist Gallwitz, Monika Kellerer, Harald H. Klein, Dirk Müller-Wieland, Michael A. Nauck, Tobias Wiesner, Erhard Siegel
https://doi.org/10.1007/s11428-023-01144-y
2024, Die Diabetologie, №2, с.212-260
Scopus
WoS
Цитувань Crossref:0
Metformin Protects Cardiovascular Health in People With Diabetes
Chong Chen, Shiqi Yuan, Xuenuo Zhao, Mengmeng Qiao, Shuna Li, Ningxia He, Liying Huang, Jun Lyu
https://doi.org/10.3389/fcvm.2022.949113 ·
2022, Frontiers in Cardiovascular Medicine
Scopus
WoS
Цитувань Crossref:0
Look AHEAD to Precision Prevention in Type 2 Diabetes
Paul W Franks
https://doi.org/10.1210/clinem/dgae061 ·
2024, The Journal of Clinical Endocrinology & Metabolism
Scopus
WoS
Цитувань Crossref:0
Associations of Combined Healthy Lifestyle Factors with Risks of Diabetes, Cardiovascular Disease, Cancer, and Mortality Among Adults with Prediabetes: Four Prospective Cohort Studies in China, the United Kingdom, and the United States
Zhou-Zheng Tu, Qi Lu, Yan-Bo Zhang, Zhe Shu, Yu-Wei Lai, Meng-Nan Ma, Peng-Fei Xia, Ting-Ting Geng, Jun-Xiang Chen, Yue Li, Lin-Jing Wu, Jing Ouyang, Zhi Rong, Xiong Ding, Xu Han, Shuo-Hua Chen, Mei-An He, Xiao-Min Zhang, Lie-Gang Liu, Tang-Chun Wu, Shou-Ling Wu, Gang Liu, An Pan
https://doi.org/10.1016/j.eng.2022.04.010 ·
2023, Engineering, с.141-148
Scopus
WoS
Цитувань Crossref:1
Feasibility of a Type 2 Diabetes Prevention Program at Nationwide Level in General Practice: A Pilot Study in Italy
Rosalba La Grotta, Valeria Pellegrini, Francesco Prattichizzo, Oriana Amata, Lorenzo Panella, Antonio Frizziero, Marco Visconti, Gabriella Averame, Pier Claudio Brasesco, Ilaria Calabrese, Olga Vaccaro, Antonio Ceriello
https://doi.org/10.3390/jcm13041127 ·
2024, Journal of Clinical Medicine, №4, с.1127
Scopus
WoS
Цитувань Crossref:0
Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes
João Sérgio Neves, Connie Newman, John A. Bostrom, Martin Buysschaert, Jonathan D. Newman, José Luiz Medina, Ira J. Goldberg, Michael Bergman
https://doi.org/10.1016/j.diabres.2022.109980 ·
2022, Diabetes Research and Clinical Practice, с.109980
Scopus
WoS
Цитувань Crossref:15
Update Typ-2-Diabetes
Andreas Hamann
https://doi.org/10.1007/s11428-022-00929-x
2022, Die Diabetologie, №5, с.527-541
Scopus
WoS
Цитувань Crossref:0
1-h post-load plasma glucose for detecting early stages of prediabetes
M. Buysschaert, M. Bergman, P. Valensi
https://doi.org/10.1016/j.diabet.2022.101395 ·
2022, Diabetes & Metabolism, №6, с.101395
Scopus
WoS
Цитувань Crossref:0